Next Science Limited (NXSCF)
OTCMKTS
· Delayed Price · Currency is USD
0.0550
0.00 (0.00%)
May 9, 2025, 4:00 PM EDT
Next Science Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Net Income | -10.59 | -16.27 | -12.68 | -9.35 | -11.91 | Upgrade
|
| Depreciation & Amortization | 0.73 | 0.74 | 0.6 | 0.55 | 0.5 | Upgrade
|
| Other Amortization | 0.55 | 0.38 | 0.29 | 0.24 | 0.2 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0 | 0 | 0.01 | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.08 | 0.03 | 0.04 | 0.01 | 0.01 | Upgrade
|
| Stock-Based Compensation | 1.01 | 0.13 | 0.01 | 0.11 | 0.51 | Upgrade
|
| Other Operating Activities | 0.23 | 0.35 | 0.05 | -0.09 | -0.05 | Upgrade
|
| Change in Accounts Receivable | 0.25 | -1.91 | -0.81 | 2.5 | -2.1 | Upgrade
|
| Change in Inventory | 0 | 0.27 | 0.56 | -0.39 | -0.63 | Upgrade
|
| Change in Accounts Payable | -0.55 | 1.35 | 0.81 | 0.11 | -0.03 | Upgrade
|
| Change in Unearned Revenue | -0.27 | -0.27 | -0.27 | -1.91 | 1.58 | Upgrade
|
| Change in Other Net Operating Assets | 0.59 | 0.15 | -0.39 | -0.06 | 0 | Upgrade
|
| Operating Cash Flow | -7.96 | -15.06 | -11.79 | -8.26 | -11.91 | Upgrade
|
| Capital Expenditures | -0.05 | -0.3 | -0.09 | -0.14 | -0.21 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.54 | -0.59 | -0.39 | -0.58 | -0.47 | Upgrade
|
| Investment in Securities | - | -0 | 0.33 | - | - | Upgrade
|
| Investing Cash Flow | -0.59 | -0.88 | -0.15 | -0.72 | -0.69 | Upgrade
|
| Long-Term Debt Issued | 2 | 6.98 | - | - | - | Upgrade
|
| Total Debt Issued | 2 | 6.98 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -0.25 | -0.27 | -0.25 | -0.21 | -0.22 | Upgrade
|
| Net Debt Issued (Repaid) | 1.75 | 6.71 | -0.25 | -0.21 | -0.22 | Upgrade
|
| Issuance of Common Stock | - | 14.04 | 10.89 | 1.65 | 11.32 | Upgrade
|
| Other Financing Activities | 0 | -0.64 | -0.39 | -0.01 | -0.39 | Upgrade
|
| Financing Cash Flow | 1.75 | 20.11 | 10.25 | 1.43 | 10.71 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.76 | 0 | -0.24 | -0.42 | 0.31 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | Upgrade
|
| Net Cash Flow | -7.56 | 4.17 | -1.93 | -7.97 | -1.57 | Upgrade
|
| Free Cash Flow | -8.01 | -15.35 | -11.88 | -8.4 | -12.12 | Upgrade
|
| Free Cash Flow Margin | -35.10% | -69.23% | -101.42% | -93.93% | -352.22% | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.07 | -0.06 | -0.04 | -0.07 | Upgrade
|
| Levered Free Cash Flow | -5.09 | -10.39 | -6.81 | -5.45 | -8.3 | Upgrade
|
| Unlevered Free Cash Flow | -4.95 | -9.91 | -6.79 | -5.44 | -8.29 | Upgrade
|
| Change in Net Working Capital | 0.26 | 0.32 | -0.69 | -0.37 | 1.01 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.